Martin Gore

P138 Outcomes of children undergoing clinically indicated bronchoscopy for severe recurrent respiratory symptoms

J Ngeh, Kushalinii Hillson, Keisha Bonner, Polly Robinson et autres

gb (code pays fourni par la source)

S45 Mart vs conventional therapy: impact on biomarkers, lung function and symptom control in children and young people with asthma

S Hay, Kushalinii Hillson, Hernani Almeida, B Pavlou et autres

gb, gr (code pays fourni par la source)

An overview on a Computer-Aided Drug Designby Pharmacophore modelling and Virtual screening approach.

Krushna Bapusaheb Jare, Martin Gore, Dr.Megha T.Salve

in (code pays fourni par la source)

Carboplatin dosage: prospective evaluation of a simple formula based on renal function.

A. Hilary Calvert, David R. Newell, Lindsey Gumbrell, Séamus O’Reilly et autres

Data from Preclinical Evidence That Trametinib Enhances the Response to Antiangiogenic Tyrosine Kinase Inhibitors in Renal Cell Carcinoma

Victoria L. Bridgeman, Elaine Y. Wan, Shane Foo, Mark R. Nathan et autres

gb, be (code pays fourni par la source)

Supplementary Figures 1-5 and Supplementary Table 1 from Preclinical Evidence That Trametinib Enhances the Response to Antiangiogenic Tyrosine Kinase Inhibitors in Renal Cell Carcinoma

Victoria L. Bridgeman, Elaine Y. Wan, Shane Foo, Mark R. Nathan et autres

Supplementary Figures 1-5 and Supplementary Table 1 from Preclinical Evidence That Trametinib Enhances the Response to Antiangiogenic Tyrosine Kinase Inhibitors in Renal Cell Carcinoma

Victoria L. Bridgeman, Elaine Y. Wan, Shane Foo, Mark R. Nathan et autres

Data from Preclinical Evidence That Trametinib Enhances the Response to Antiangiogenic Tyrosine Kinase Inhibitors in Renal Cell Carcinoma

Victoria L. Bridgeman, Elaine Y. Wan, Shane Foo, Mark R. Nathan et autres

Supplementary Figure S1 from Inhibiting EGF Receptor or SRC Family Kinase Signaling Overcomes BRAF Inhibitor Resistance in Melanoma

María Romina Girotti, Malin Pedersen, Berta Sanchez‐Laorden, Amaya Virós et autres

Supplementary Material from Inhibiting EGF Receptor or SRC Family Kinase Signaling Overcomes BRAF Inhibitor Resistance in Melanoma

María Romina Girotti, Malin Pedersen, Berta Sanchez‐Laorden, Amaya Virós et autres

Supplementary Table S6 from Inhibiting EGF Receptor or SRC Family Kinase Signaling Overcomes BRAF Inhibitor Resistance in Melanoma

María Romina Girotti, Malin Pedersen, Berta Sanchez‐Laorden, Amaya Virós et autres

Supplementary Table S4 from Inhibiting EGF Receptor or SRC Family Kinase Signaling Overcomes BRAF Inhibitor Resistance in Melanoma

María Romina Girotti, Malin Pedersen, Berta Sanchez‐Laorden, Amaya Virós et autres